68Ga PSMA PET/MR in the differentiation of low and high grade gliomas: Is 68Ga PSMA PET/MRI useful to detect brain gliomas?

被引:14
|
作者
Akgun, Elife [1 ]
Akgun, Mehmet Yigit [2 ]
Selcuk, Hatem Hakan [3 ]
Uzan, Mustafa [4 ]
Sayman, Haluk Burcak [5 ]
机构
[1] High Specialized Hosp, Dept Nucl Med, Kirikkale, Turkey
[2] High Specialized Hosp, Dept Neurosurg, Kirikkale, Turkey
[3] Dr Sadi Konuk Training & Res Hosp, Dept Radiol, Istanbul, Turkey
[4] Istanbul Univ Cerrahpasa, Cerrahpasa Med Fac, Dept Neurosurg, Istanbul, Turkey
[5] Istanbul Univ Cerrahpasa, Cerrahpasa Med Fac, Dept Nucl Med, Istanbul, Turkey
关键词
Glial tumor; Grade(68)Ga PSMA; PET/MR;
D O I
10.1016/j.ejrad.2020.109199
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: Magnetic resonance imaging (MRI) is the most important imaging modality in the diagnosis and follow-up of glial brain tumors. Objective: The aim of our study is to determine the correlation between tumor grade, determined with postoperative pathological examination, and standard uptake value (SUV), a semi-quantitative parameter, in patients who underwent imaging Ga-68-PSMA with using PET/MR. Material-method: Thirty-five out of 38 patients' images whose pathology was consistent with glial tumor, 42 lesions from separate anatomic localizations or with higher activity uptake than the rest of the tumor were evaluated. SUV values measured on PET images and grade relationship were evaluated based on each lesion while mitosis, Ki-67 were evaluated for each patient. Results: Grade, Ki-67, mitosis, necrosis and SUVmax/mean/peak were found statistically significant with moderate/high correlation. The parameter with the highest correlation coefficient was mitosis. (For SUVmax r = 0.64, p = 0). When Grade II and III were considered as the first group and IV as the second group, the cutoff values were found to be 2.3 for SUVmax, 0.21 for SUVmean and 0.63 for SUVpeak. In the diagnosis of HGG, PET's sensitivity is higher than MRI but no statistically difference was found between specificities. Conclusion: Ga-68 PSMA PET imaging is found to be particularly useful in differentiating Grade IV glial tumors from other grades. This finding is thought to be important in the differentiation the relapse with postoperative tissue changes, which is an important problem in the follow-up.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] IMPACT OF DELAYED IMAGING ON INTERPRETATION OF [68GA]-PSMA PET IN PROSTATE CANCER
    Schembri, G.
    Zhou, W.
    Bailey, D. L.
    Kneebone, A.
    Eade, T.
    Roach, P.
    Hsiao, E.
    INTERNAL MEDICINE JOURNAL, 2015, 45 : 16 - 16
  • [22] Predictor of 68Ga PSMA PET/CT positivity in patients with prostate cancer
    Soydal, Cigdem
    Urun, Yuksel
    Suer, Evren
    Nak, Demet
    Ozkan, Elgin
    Kucuk, Nuriye O.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 64 (02): : 226 - 230
  • [23] Serous Cystadenoma of the Pancreas Showing Uptake on 68Ga PSMA PET/CT
    Chan, Mico
    Schembri, Geoffrey Paul
    Hsiao, Edward
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (01) : 56 - 57
  • [24] [68Ga]Ga-PSMA-11 PET/CT in Thyroid Cancer Preliminary Results
    Zajkowska, K.
    Wojewodzka-Mirocha, M.
    Cegla, P.
    Sackiewicz, A.
    Ochman, P.
    Januszkiewicz-Caulier, J.
    Zylka, A.
    Dedecjus, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S549 - S550
  • [25] [68Ga]GaFAPI-RGD PET/CT in the evaluation of renal carcinoma: comparison with [18F]FDG/[68Ga]Ga-PSMA PET/CT
    Lin, R.
    Zang, J.
    Wang, C.
    Chen, S.
    Zhang, J.
    Yang, Y.
    Xu, F.
    Zhang, J.
    Chen, X.
    Miao, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S166 - S166
  • [26] Selection of Optimal Quantification Metric in Static Prostate Cancer Imaging with the PSMA-targeted [68Ga]Ga-PSMA-11 and [68Ga]Ga-P16093 PET Radiopharmaceuticals
    Territo, Wendy
    Hutchins, Gary
    Clint, Bahler
    Tann, Mark
    Collins, Katrina
    Mathias, Carla
    Alexoff, David
    Kung, Hank
    Green, Mark
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [27] [68Ga]Ga-PSMA PET/MRI, histological PSMA expression and preliminary experience with [177Lu]Lu-PSMA therapy in relapsing high-grade glioma
    Truckenmueller, Peter
    Graef, Josefine
    Scheel, Michael
    Vajkoczy, Peter
    Capper, David
    Kaul, David
    Furth, Christian
    Amthauer, Holger
    Brenner, Winfried
    Onken, Julia Sophie
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [28] Can 68Ga PSMA PET/CT be useful in assessment of response to treatment in patients with carcinoma prostate?
    Rangarajan, Venkatesh
    Mhatre, Nihit
    Agrawal, Archi
    Shah, Sneha
    Purandare, Nilendu
    Puranik, Ameya
    Prakash, Gagan
    Bakshi, Ganesh
    Joshi, Amit
    Prabhash, Kumar
    Noronha, Vanita
    Pal, Mahendra
    Murthy, Vedang
    Krishnatry, Rahul
    Menon, Santosh
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [29] Preparation of [68Ga]Ga-Chloride from 68Zn solid target for the synthesis of pharmaceutical grade [68Ga]Ga-PSMA-11 and [68Ga]Ga-DOTA-TATE
    Chattopadhyay, Sankha
    Ash, Shayantani
    Mahesh, D. G.
    Barua, Luna
    Mitra, Arpit
    Das, Sujata Saha
    Singha, Samarjit
    Nayer, Md Alam
    Kumar, Umesh
    Sinha, Samarendu
    APPLIED RADIATION AND ISOTOPES, 2023, 195
  • [30] Prospective evaluation of the role of 68Ga-PSMA PET/CT in recurrent high grade gliomas.
    Kumar, Arunav
    Arunraj, Sreedharan
    Tripathi, Madhavi
    Haresh, K. P.
    Gupta, Subhash
    Damle, Nishikant
    Singh, Manmohan
    Hemrom, Angel
    Reddy, Sreenivasa
    Yadav, Madhav
    Bal, Chandrasekhar
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61